These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1319488)

  • 21. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Maeda T; Takahashi T; Ohkawara S; Yoshinaga M
    Lab Invest; 1998 May; 78(5):559-69. PubMed ID: 9605181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytokine network involved in inflammatory reactions].
    Mukaida N
    Rinsho Byori; 1997 Jun; 45(6):513-8. PubMed ID: 9306708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokines, receptors, and inhibitors.
    Gehr G; Braun T; Lesslauer W
    Clin Investig; 1992 Jan; 70(1):64-9. PubMed ID: 1318126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of proinflammatory cytokines in lung ischemia-reperfusion injury.
    Krishnadasan B; Naidu BV; Byrne K; Fraga C; Verrier ED; Mulligan MS
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):261-72. PubMed ID: 12579094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases.
    Xanthoulea S; Pasparakis M; Kousteni S; Brakebusch C; Wallach D; Bauer J; Lassmann H; Kollias G
    J Exp Med; 2004 Aug; 200(3):367-76. PubMed ID: 15289505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases.
    Dinarello CA
    Curr Opin Immunol; 1991 Dec; 3(6):941-8. PubMed ID: 1665333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis.
    Corrigall VM; Bodman-Smith MD; Brunst M; Cornell H; Panayi GS
    Arthritis Rheum; 2004 Apr; 50(4):1164-71. PubMed ID: 15077298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biology of proinflammatory cytokines and their antagonists.
    Moldawer LL
    Crit Care Med; 1994 Jul; 22(7):S3-7. PubMed ID: 8026189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].
    Meyer O
    Bull Acad Natl Med; 2003; 187(5):935-54; discussion 954-5. PubMed ID: 14979058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of cytokines and growth factors in joint destruction processes].
    Alsalameh S; Jerez R; Bujía J; Haeupl T; Kalden JR; Burmester GR
    Rev Med Chil; 1992 Dec; 120(12):1400-10. PubMed ID: 1343382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor alpha, interleukin-1beta, and interleukin-8 from peripheral blood monocytes via Fc gamma receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis.
    Mullazehi M; Mathsson L; Lampa J; Rönnelid J
    Arthritis Rheum; 2006 Jun; 54(6):1759-71. PubMed ID: 16736518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin.
    West DA; James NH; Cosulich SC; Holden PR; Brindle R; Rolfe M; Roberts RA
    Hepatology; 1999 Dec; 30(6):1417-24. PubMed ID: 10573520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha.
    Romero R; Maymon E; Pacora P; Gomez R; Mazor M; Yoon BH; Berry SM
    Am J Obstet Gynecol; 2000 Nov; 183(5):1070-7. PubMed ID: 11084543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice.
    Rosenbaum JT; Han YB; Park JM; Kennedy M; Planck SR
    J Rheumatol; 1998 Dec; 25(12):2408-16. PubMed ID: 9858438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importance of systemic cytokines in the pathogenesis of polymicrobial sepsis and dehydroepiandrosterone treatment in a rodent model.
    Hildebrand F; Pape HC; Hoevel P; Krettek C; van Griensven M
    Shock; 2003 Oct; 20(4):338-46. PubMed ID: 14501948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways.
    Carlson NG; Wieggel WA; Chen J; Bacchi A; Rogers SW; Gahring LC
    J Immunol; 1999 Oct; 163(7):3963-8. PubMed ID: 10490998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mode of action of cytokine inhibitors.
    Arend WP
    J Rheumatol Suppl; 2002 Sep; 65():16-21. PubMed ID: 12236617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Setting the cytokine trap for autoimmunity.
    Dinarello CA
    Nat Med; 2003 Jan; 9(1):20-2. PubMed ID: 12514715
    [No Abstract]   [Full Text] [Related]  

  • 40. Endogenous interleukin-6, but not tumor necrosis factor alpha, contributes to the development of toll-like receptor 4/myeloid differentiation factor 88-mediated acute arthritis in mice.
    Kyo F; Futani H; Matsui K; Terada M; Adachi K; Nagata K; Sano H; Tateishi H; Tsutsui H; Nakanishi K
    Arthritis Rheum; 2005 Aug; 52(8):2530-40. PubMed ID: 16052598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.